Drugs / TD1414
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00758862 | Dec 2008 → Feb 2009 | impetigo, wound myiasis | LEO Pharma | Completed | No outcome recorded |
| Phase 2 | NCT00626795 | Feb 2008 → Mar 2009 | impetigo | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TD1414 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00758862 ↗ |
| Route | Topical | “2% TD1414 Cream” NCT00758862 ↗ |